Ebel Noelle H, Hsu Evelyn K, Berry Kristin, Horslen Simon P, Ioannou George N
1 Department of Pediatrics, University of Washington School of Medicine, Seattle, WA. 2 Center for Clinical and Translational Research, Seattle Children's Research Institute, Seattle, WA. 3 Research and Development, Veterans Affairs Puget Sound Healthcare System, Seattle, WA. 4 Department of Medicine, Veterans Affairs Puget Sound Healthcare System and University of Washington, Seattle, WA.
Transplantation. 2017 Jul;101(7):1616-1627. doi: 10.1097/TP.0000000000001689.
We evaluated liver transplantation waitlist and posttransplantation outcomes in those aged 18 to 24 years compared with both younger (0-17 years) and older (25-34 years) registrants and recipients.
Using national data from the United Network for Organ Sharing, competing risk, Cox regression and Kaplan-Meier analyses were performed on first-time liver transplant registrants (n = 13 979) and recipients (n = 8718) ages 0 to 34 years between 2002 and 2015.
Nonstatus 1A registrants, registrants aged 0 to 17 and 25 to 34 years were less likely to experience dropout from the waiting list compared with those aged 18 to 24 years (adjusted hazard ratio, 0-5 years = 0.36; 6-11 = 0.29; 12-17 = 0.48; 18-24 = 1.00; 25-34 = 0.82). Although there was no difference in risk of graft failure across all age groups, both younger and older age groups had significantly lower risk of posttransplant mortality compared with those aged 18 to 24 years (adjusted hazard ratio, for 0-5 years = 0.53, 6-11 = 0.48, 12-17 = 0.70, 18-24 = 1.00, 25-34 = 0.77). This may be related to lower likelihood of retransplantation after graft failure in those aged 18 to 24 years.
This national registry study demonstrates for the first time poorer waitlist and postliver transplant outcomes in young adults ages 18 to 24 years at the time of listing and transplantation compared to older and younger age groups. Given the potential survival benefit in transplanting young adults and the shortage of solid organs for transplant, future studies are critical to identify and target modifiable risk factors to improve waitlist and long-term posttransplant outcomes in 18- to 24-year-old registrants and recipients.
我们评估了18至24岁人群在肝移植等待名单上的情况以及移植后的结局,并与年龄较小(0至17岁)和较大(25至34岁)的登记者及受者进行了比较。
利用器官共享联合网络的全国性数据,对2002年至2015年间年龄在0至34岁的首次肝移植登记者(n = 13979)和受者(n = 8718)进行了竞争风险、Cox回归和Kaplan-Meier分析。
与18至24岁的登记者相比,非1A状态的登记者、0至17岁以及25至34岁的登记者从等待名单上退出的可能性较小(调整后的风险比,0至5岁 = 0.36;6至11岁 = 0.29;12至17岁 = 0.48;18至24岁 = 1.00;25至34岁 = 0.82)。尽管所有年龄组的移植失败风险没有差异,但与18至24岁的受者相比,年龄较小和较大的年龄组移植后死亡风险均显著较低(调整后的风险比,0至5岁 = 0.53,6至11岁 = 0.48,12至17岁 = 0.70,18至24岁 = 1.00,25至34岁 = 0.77)。这可能与18至24岁的受者移植失败后再次移植的可能性较低有关。
这项全国性登记研究首次表明,与年龄较大和较小的年龄组相比,18至24岁的年轻成年人在列入等待名单和移植时,等待名单和肝移植后的结局较差。鉴于移植年轻成年人可能带来生存益处以及可供移植的实体器官短缺,未来的研究对于识别和针对可改变的风险因素以改善18至24岁登记者和受者的等待名单情况及长期移植后结局至关重要。